• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression, clinical significance and correlation of RUNX3 and HER2 in colorectal cancer.RUNX3和HER2在结直肠癌中的表达、临床意义及相关性
J Gastrointest Oncol. 2021 Aug;12(4):1577-1589. doi: 10.21037/jgo-21-403.
2
Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.RUNX3 通过 Notch 信号通路对结直肠癌细胞生物学特性的影响。
Int J Oncol. 2017 Jun;50(6):2059-2068. doi: 10.3892/ijo.2017.3988. Epub 2017 May 8.
3
Epigenetic inactivation of in colorectal cancer.结直肠癌中[具体基因或其他相关因素]的表观遗传失活
Ann Surg Treat Res. 2018 Jan;94(1):19-25. doi: 10.4174/astr.2018.94.1.19. Epub 2017 Dec 28.
4
Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.RUNX3基因在乳腺癌及乳腺癌细胞系中的表达、甲基化状态及临床病理意义
Pathobiology. 2008;75(4):244-51. doi: 10.1159/000132385. Epub 2008 Jun 26.
5
Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis.RUNX3 高甲基化频率与结直肠癌的临床意义及相关性:一项荟萃分析。
Onco Targets Ther. 2014 Jul 10;7:1237-45. doi: 10.2147/OTT.S62103. eCollection 2014.
6
Correlation of HER2 and FOXM1 in human colorectal carcinoma and its clinical significance.人结直肠癌中HER2与FOXM1的相关性及其临床意义
Int J Clin Exp Pathol. 2017 Dec 1;10(12):11624-11634. eCollection 2017.
7
Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.miR-301a-3p 的过表达通过靶向肝癌缺失基因 1 和 runt 相关转录因子 3 促进结直肠癌细胞的增殖和转移。
J Cell Biochem. 2019 Apr;120(4):6078-6089. doi: 10.1002/jcb.27894. Epub 2018 Oct 25.
8
The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.EZH2 和 DNA 甲基化在结直肠癌中肿瘤抑制因子 RUNX3 沉默中的作用。
Carcinogenesis. 2010 Sep;31(9):1567-75. doi: 10.1093/carcin/bgq147. Epub 2010 Jul 14.
9
Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.EGFR、Her2 的表达可预测结直肠癌中与淋巴结转移(LNM)相关的转移。
Cancer Biomark. 2012;11(5):219-26. doi: 10.3233/CBM-2012-00282.
10
[Expression of Runx3 and C-myc in human colorectal cancer].
Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(7):1042-7.

引用本文的文献

1
RUNX transcription factors: biological functions and implications in cancer.RUNX 转录因子:生物学功能及其在癌症中的意义。
Clin Exp Med. 2024 Mar 2;24(1):50. doi: 10.1007/s10238-023-01281-0.
2
Somatic Copy Number Alterations in Colorectal Cancer Lead to a Differentially Expressed ceRNA Network (ceRNet).结直肠癌中的体细胞拷贝数改变导致差异表达的竞争性内源RNA网络(ceRNet)。
Curr Issues Mol Biol. 2023 Nov 28;45(12):9549-9565. doi: 10.3390/cimb45120597.
3
Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer.联合检测RUNX3和EZH2评估新辅助治疗疗效及中低位局部进展期直肠癌的预后价值
Front Oncol. 2022 Feb 24;12:713335. doi: 10.3389/fonc.2022.713335. eCollection 2022.

本文引用的文献

1
[Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2020 edition)].《中国结直肠癌诊疗规范(2020年版)》
Zhonghua Wai Ke Za Zhi. 2020 Aug 1;58(8):561-585. doi: 10.3760/cma.j.cn112139-20200518-00390.
2
Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib.吡咯替尼对HER2阳性胃癌细胞的治疗促进释放的外泌体增强内皮细胞进展,这一作用可被阿帕替尼抵消。
Onco Targets Ther. 2019 Apr 11;12:2777-2787. doi: 10.2147/OTT.S194768. eCollection 2019.
3
Runx3 inhibits endothelial progenitor cell differentiation and function via suppression of HIF-1α activity.Runx3 通过抑制 HIF-1α 的活性来抑制内皮祖细胞的分化和功能。
Int J Oncol. 2019 Apr;54(4):1327-1336. doi: 10.3892/ijo.2019.4713. Epub 2019 Feb 11.
4
Plasma HER2 () Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer.血浆 HER2()拷贝数预测转移性结直肠癌对 HER2 靶向治疗的反应。
Clin Cancer Res. 2019 May 15;25(10):3046-3053. doi: 10.1158/1078-0432.CCR-18-3389. Epub 2019 Feb 26.
5
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer.谱系追踪揭示结直肠癌中 T 细胞的动态关系。
Nature. 2018 Dec;564(7735):268-272. doi: 10.1038/s41586-018-0694-x. Epub 2018 Oct 29.
6
Adipose-derived stem cell-derived microvesicle-released miR-210 promoted proliferation, migration and invasion of endothelial cells by regulating RUNX3.脂肪干细胞来源的微小囊泡释放的 miR-210 通过调节 RUNX3 促进内皮细胞的增殖、迁移和侵袭。
Cell Cycle. 2018;17(8):1026-1033. doi: 10.1080/15384101.2018.1480207. Epub 2018 Jul 5.
7
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer.转移性结直肠癌患者中 HER2 扩增的预后和预测价值。
Clin Colorectal Cancer. 2018 Sep;17(3):198-205. doi: 10.1016/j.clcc.2018.05.006. Epub 2018 May 19.
8
Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.基于人表皮生长因子 2 状态的Ⅱ-Ⅲ期胃癌生存分析。
World J Gastroenterol. 2017 Nov 7;23(41):7407-7414. doi: 10.3748/wjg.v23.i41.7407.
9
USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.USP7 通过介导β-catenin 去泛素化作用成为 APC 突变型结直肠癌的肿瘤特异性 WNT 激活剂。
Cell Rep. 2017 Oct 17;21(3):612-627. doi: 10.1016/j.celrep.2017.09.072.
10
Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma.肝细胞癌中p16、SLIT2、SCARA5和Runx3基因的甲基化分析
Medicine (Baltimore). 2017 Oct;96(41):e8279. doi: 10.1097/MD.0000000000008279.

RUNX3和HER2在结直肠癌中的表达、临床意义及相关性

Expression, clinical significance and correlation of RUNX3 and HER2 in colorectal cancer.

作者信息

Wu Yunshi, Xue Jun, Li Yuanrui, Wu Xueliang, Qu Ming, Xu Dandan, Shi Yongquan

机构信息

Graduate School of Hebei North University, Zhangjiakou, China.

Department of General Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.

出版信息

J Gastrointest Oncol. 2021 Aug;12(4):1577-1589. doi: 10.21037/jgo-21-403.

DOI:10.21037/jgo-21-403
PMID:34532112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421900/
Abstract

BACKGROUND

The incidence of colorectal cancer is high and on the rise. The genetic and protein expressions of RUNT-associated transcription factor 3 (RUNX3) and human epidermal growth factor receptor 2 (HER2) in colorectal cancer (CRC) and adjacent normal tissues were detected to preliminarily explore their correlation and clinical significance.

METHODS

CRC specimens excised during general surgery were selected for localization and quantitative analysis of protein and gene expression by SP (Streptavidin-peroxidase conjugated method) immunohistochemical staining, reverse transcription-polymerase chain reaction (RT-qPCR) and western blot. Combined with the patients' data, the relationship between the expression of the two genes and tumor characteristics was analyzed. Log-rank test was used to analyze the correlation between the two proteins and survival prognosis of CRC patients. The expression of RUNX3 in RKO and HCT-116 was knocked down, and the relative expression of HER2 in the two cell lines was detected.

RESULTS

Immunohistochemical, RT-qPCR and Western blot results showed that the positive expression rate of RUNX3 in CRC was lower than in the normal group, and HER2 in CRC was higher than in the normal group. The positive expression of the two proteins correlated with the pT and pN stages of CRC. A significant negative correlation between the expression of the two genes in CRC. Follow-up results showed that the number of -positive patients was higher than negative ones, while positive were fewer than negative ones. In vitro experiments showed that protein and gene expression decreased, HER2 protein and gene expression increased in knockdown RKO and HCT-116 cells, respectively (P<0.05).

CONCLUSIONS

The expression of and in CRC is related to the occurrence and development of CRC, and the two genes have a negative regulating effect.

摘要

背景

结直肠癌发病率高且呈上升趋势。检测 runt 相关转录因子 3(RUNX3)和人表皮生长因子受体 2(HER2)在结直肠癌(CRC)及癌旁正常组织中的基因及蛋白表达,初步探讨其相关性及临床意义。

方法

选取普通外科手术切除的 CRC 标本,采用链霉亲和素 - 过氧化物酶结合法(SP)免疫组化染色、逆转录 - 聚合酶链反应(RT - qPCR)及蛋白质印迹法进行蛋白和基因表达的定位及定量分析。结合患者资料,分析两个基因的表达与肿瘤特征的关系。采用对数秩检验分析两种蛋白与 CRC 患者生存预后的相关性。敲低 RKO 和 HCT - 116 细胞中 RUNX3 的表达,检测两种细胞系中 HER2 的相对表达。

结果

免疫组化、RT - qPCR 和蛋白质印迹结果显示,CRC 中 RUNX3 的阳性表达率低于正常组,HER2 在 CRC 中的表达高于正常组。两种蛋白的阳性表达与 CRC 的 pT 和 pN 分期相关。CRC 中两个基因的表达呈显著负相关。随访结果显示,双阳性患者数量高于双阴性患者,而单阳性患者数量少于单阴性患者。体外实验表明,敲低 RKO 和 HCT - 116 细胞中的 RUNX3 后,HER2 蛋白和基因表达分别增加,RUNX3 蛋白和基因表达降低(P<0.05)。

结论

RUNX3 和 HER2 在 CRC 中的表达与 CRC 的发生发展有关,且两个基因具有负调控作用。